Article

Hypersensitivity reactions to ophthalmic products.

Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Policlinico, Piazza G. Cesare no 11, 70124 Bari, Italy.
Current pharmaceutical design (impact factor: 4.41). 02/2006; 12(26):3401-10. pp.3401-10
Source: PubMed

ABSTRACT Adverse reactions after administration of ophthalmic products have frequently been observed. These reactions can be provoked by both active principles and excipients. Different pathogenic mechanisms have been suggested for such reactions, including immunologic ones. Basophils and mast cells participate in IgE-mediated reactions through the release of mediators like histamine and tryptase, whereas a T-cell-mediated pathogenic mechanism is involved in most delayed reactions, particularly conjunctival ones and eyelid dermatitis. Prick tests and immediate-reading intradermal tests are carried out to diagnose immediate hypersensitivity reactions, while patch tests are usually performed to evaluate delayed reactions. Other diagnostic tests, such as serum-specific IgE assays in immediate reactions, as well as delayed-reading intradermal tests and/or lymphocyte transformation tests in delayed ones, are rarely performed. In this review, particular attention is addressed to the clinical and practical aspects of both cell-mediated and IgE-mediated hypersensitivity reactions to ophthalmic products.

0 0
 · 
0 Bookmarks
 · 
34 Views

Keywords

active principles
 
Adverse reactions
 
cell-mediated
 
delayed-reading intradermal tests
 
diagnose immediate hypersensitivity reactions
 
Different pathogenic mechanisms
 
eyelid dermatitis
 
IgE-mediated hypersensitivity reactions
 
IgE-mediated reactions
 
immediate reactions
 
immediate-reading intradermal tests
 
immunologic ones
 
lymphocyte transformation tests
 
mast cells
 
ophthalmic products
 
particular attention
 
practical aspects
 
reactions
 
serum-specific IgE assays
 
T-cell-mediated pathogenic mechanism
 

M T Ventura